Foresite Capital Management Iv, LLC Tempest Therapeutics, Inc. Transaction History

Foresite Capital Management Iv, LLC

  • $153 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$5.28 - $15.2 $1 Million - $2.89 Million
-190,213 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$10.49 - $24.19 $10 - $24
1 Added 0.0%
190,213 $2.75 Million
Q2 2021

Aug 16, 2021
BUY
$11.18 - $22.95 $2.13 Million - $4.37 Million
190,212 New
190,212 $2.13 Million

Others Institutions Holding TPST

# of Institutions
35
Shares Held
2.46M
Call Options Held
44.9K
Put Options Held
109K
View Full List

About Tempest Therapeutics, Inc.

TPST Quotes by TradingView
  • Ticker TPST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,418,900
  • Market Cap $9.59M
  • Description
  • Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...
More about TPST
Track This Portfolio

Track Foresite Capital Management Iv, LLC Portfolio

Follow Foresite Capital Management Iv, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresite Capital Management Iv, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foresite Capital Management Iv, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email